Literature DB >> 6847195

An exploration of the primary specificity site of cathepsin B.

E Shaw, P Wikstrom, J Ruscica.   

Abstract

Peptidyl diazomethyl ketones inactivate cathepsin B apparently by alkylation of the active center thiol following complex formation as in the case of benzyloxycarbonyl (Cbz)-Phe-AlaCHN2. The phenylalanine contributes considerably to binding in the secondary specificity site. In order to define the topography of the active center region comprising the primary specificity site of beef spleen cathepsin B, a series of peptidyl diazomethyl ketones having the general structure Cbz-Phe-X-CHN2 has now been synthesized. The amino acid, X, has been varied in size to include rather large side chains which might reveal available binding potential or limitations. Some of the reagents, in fact, were not inhibitory even at 10(-4) M. Others, however, that did measurably inactivate cathepsin B provided a range of reactivities that extended over 5 orders of magnitude and correlated with affinity in the reversible phase of inactivation. Some large side chains, for example, that of tryptophan, were very poorly tolerated in this region of the active center, whereas others, such as O-benzyl threonine, provided remarkably active inhibitors. A topographical rationalization of the results is offered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847195     DOI: 10.1016/0003-9861(83)90540-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.

Authors:  H Angliker; P Wikstrom; H Kirschke; E Shaw
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B.

Authors:  B Walker; B M Cullen; G Kay; I M Halliday; A McGinty; J Nelson
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

4.  The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.

Authors:  B M Cullen; I M Halliday; G Kay; J Nelson; B Walker
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

5.  Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor.

Authors:  Dongmei Yang; Yuxia Han; Jianfeng Zhang; Christopher Ding; John Anagli; Donald M Seyfried
Journal:  J Neurosurg       Date:  2010-07-30       Impact factor: 5.115

6.  Synthesis and properties of Cbz-Phe-Arg-CHN2 (benzyloxycarbonylphenylalanylarginyldiazomethane) as a proteinase inhibitor.

Authors:  A Zumbrunn; S Stone; E Shaw
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

7.  Specificity of cathepsin B to fluorescent substrates containing benzyl side-chain-substituted amino acids at P1 subsite.

Authors:  E Del Nery; L C Alves; R L Melo; M H Cesari; L Juliano; M A Juliano
Journal:  J Protein Chem       Date:  2000-01

8.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

9.  Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.

Authors:  D H Pliura; B J Bonaventura; R A Smith; P J Coles; A Krantz
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain.

Authors:  John Anagli; Kadija Abounit; Paul Stemmer; Yuxia Han; Lisa Allred; Shantel Weinsheimer; Ashkhen Movsisyan; Donald Seyfried
Journal:  Biochem Biophys Res Commun       Date:  2007-12-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.